Phase II Evaluation of Adjuvant Hyperfractionated Radiation and Docetaxel for HPV Associated Oropharynx Cancer
Phase of Trial: Phase II
Latest Information Update: 24 Dec 2016
At a glance
- Drugs Docetaxel (Primary)
- Indications Oropharyngeal cancer
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 20 Dec 2016 Planned End Date changed from 1 Oct 2016 to 1 Oct 2017.
- 20 Oct 2016 Planned number of patients changed from 80 to 81.